The tech is also part of the company's experimental mRNA-1230, which is designed to work against COVID, influenza, and RSV. Moderna also is testing different kinds of COVID and flu shots using mRNA. Looking for Viral VulnerabilitiesResearchers have been looking for decades for ways to make flu shots that can do a better job in outsmarting the mutating virus. This approach may also have applications in developing better flu vaccines, Alberto D. López-Muñoz, PhD, MSc, a postdoctoral fellow at NIAID, told Medscape Medical News. "Explosion" in mRNA Vaccine CandidatesThe COVID-19 pandemic accelerated work long under way in seeking to develop mRNA vaccines.
Continue reading...